This company is engaged in the manufacture and sale of pharmaceutical_products. It was_incorporated in DATE DATE and has its_registered_head office in CITY,_COUNTRY. Its_main business activities are technical R&D as_well_as active_pharmaceutical_ingredients (APIs) and intermediates manufacturing. The company 's products_include MISC (valsartan) for CAUSE_OF_DEATH,_CAUSE_OF_DEATH CAUSE_OF_DEATH and post-myocardial infarction ; Exjade (deferasirox) for chronic iron overload due_to blood transfusions ; ORGANIZATION ORGANIZATION ORGANIZATION ORGANIZATION (rivastigmine tartrate & rivastigmine transdermal system) for CAUSE_OF_DEATH_CAUSE_OF_DEATH_CAUSE_OF_DEATH, and CAUSE_OF_DEATH associated_with CAUSE_OF_DEATH_CAUSE_OF_DEATH_CAUSE_OF_DEATH ; PERSON (tobramycin) for pseudomonas aeruginosa CAUSE_OF_DEATH in cystic fibrosis ; and Certican / Zortress (everolimus) for prevention of organ rejection (heart and kidney). The company has its plant in CITY. It is a_subsidiary of ORGANIZATION ORGANIZATION, a COUNTRY - based holding that,_through_its_subsidiaries, is engaged in the research,_development, manufacture and marketing of healthcare products.